7 April 2015 in The Analyst
An electrochemiluminescence sensor for highly selective and sensitive detection of lead(ii) ions (Pb2+) was developed taking advantage of the high specificity of the aptamer for Pb2+ and the use of both intermolecular and intramolecular co-reaction to achieve signal enhancement.
25 September 2014 in Chemical Communications
In this study, a single-base change discrimination strategy was developed through enhanced DNA toehold exchange reaction on a chip surface. A DNA strand with single-base change (SNPs, insertion or deletion) at an arbitrary position was clearly discriminated with nucleic acid concentrations from 0.8 nM to 1 μM through this method.
11 November 2008 in Pigment Cell & Melanoma Research
18 October 2026 in Journal of Neuroendocrinology
Digestive high‐grade neuroendocrine neoplasms (HG‐NEN) are rare and heterogeneous tumours with an aggressive biology and limited treatment efficacy. Genetic intratumour heterogeneity (ITH) is a mechanism of progression and treatment resistance in other cancers, yet unexplored in digestive HG‐NEN. Next‐generation sequencing with a 360‐cancer gene panel was performed on 51 digestive HG‐NEN, suitable for multiregional sampling. The mutational status of each sample within a patient was assessed to calculate an ITH‐index, defined as the average number of discordant mutations across all pair‐wise comparisons between samples. An ITH‐index based on primary tumour samples was calculated for chemotherapy‐naïve cases: 28 neuroendocrine carcinomas (NEC), 9 mixed neuroendocrine‐non‐neuroendocrine neoplasms (MiNEN) and 3 neuroendocrine tumour grade 3 (NET G3). Median ITH‐index in NEC/MiNEN was 5, with a wide range (0–98.8). Greater heterogeneity was associated with right‐sided colonic primaries ( p = .005) and higher tumour mutational burden ( r = 0.74, p < .001). Median overall survival was 7 months longer in NEC/MiNEN with median ITH‐index above compared to below median (22.5 vs. 15.5 months, p = .077), driven mostly by patients with locoregional disease. Response to first‐line chemotherapy was not influenced by median ITH‐index. No heterogeneity was found among driver mutations in BRAF and KRAS . NET G3 displayed low heterogeneity (ITH‐index 2–3). Higher ITH‐index was not associated with shorter survival or treatment response, suggesting that genetic ITH is not the primary resistance mechanism in digestive NEC/MiNEN. Moving towards targeted treatment strategies, our data indicate that a single biopsy may underestimate ITH. BRAF and KRAS may be favourable targets as they displayed no heterogeneity.